These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29231803)

  • 21. Small molecule kinase inhibitors as anti-cancer therapeutics.
    Chahrour O; Cairns D; Omran Z
    Mini Rev Med Chem; 2012 May; 12(5):399-411. PubMed ID: 22303944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected off-targets and paradoxical pathway activation by kinase inhibitors.
    Hantschel O
    ACS Chem Biol; 2015 Jan; 10(1):234-45. PubMed ID: 25531586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders.
    Chaudhary D; Robinson S; Romero DL
    J Med Chem; 2015 Jan; 58(1):96-110. PubMed ID: 25479567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing the selectivity of kinase inhibitors in oncology: a chemical biology perspective.
    Maddox S; Hecht D; Gustafson JL
    Future Med Chem; 2016; 8(3):241-4. PubMed ID: 26898835
    [No Abstract]   [Full Text] [Related]  

  • 25. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review).
    Ardito F; Giuliani M; Perrone D; Troiano G; Lo Muzio L
    Int J Mol Med; 2017 Aug; 40(2):271-280. PubMed ID: 28656226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence-based protein kinase inhibition: applications for drug development.
    Wexler I; Niv M; Reuveni H
    Biotechniques; 2005 Oct; 39(10 Suppl):S575-6. PubMed ID: 18957040
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluorescent biosensors - probing protein kinase function in cancer and drug discovery.
    Morris MC
    Biochim Biophys Acta; 2013 Jul; 1834(7):1387-95. PubMed ID: 23376184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Methods in Chemoproteomics with Relevance to Drug Discovery.
    Nguyen C; West GM; Geoghegan KF
    Methods Mol Biol; 2017; 1513():11-22. PubMed ID: 27807827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: six degrees of separation.
    Trusolino L; Bertotti A
    Cancer Discov; 2012 Oct; 2(10):876-80. PubMed ID: 23071031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative proteomics of kinase inhibitor targets and mechanisms.
    Daub H
    ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
    Dar AC; Shokat KM
    Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. System-based drug discovery within the human kinome.
    Bamborough P
    Expert Opin Drug Discov; 2012 Nov; 7(11):1053-70. PubMed ID: 22971083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive review of protein kinase inhibitors for cancer therapy.
    Kannaiyan R; Mahadevan D
    Expert Rev Anticancer Ther; 2018 Dec; 18(12):1249-1270. PubMed ID: 30259761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
    Verkhivker GM
    Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular basis of targeting protein kinases in cancer therapeutics.
    Tsai CJ; Nussinov R
    Semin Cancer Biol; 2013 Aug; 23(4):235-42. PubMed ID: 23651790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods in Enzymology. Protein kinase inhibitors in research and medicine. Preface.
    Shokat KM
    Methods Enzymol; 2014; 548():xi-xii. PubMed ID: 25399648
    [No Abstract]   [Full Text] [Related]  

  • 39. Checkpoint kinase inhibitors: a review of the patent literature.
    Janetka JW; Ashwell S
    Expert Opin Ther Pat; 2009 Feb; 19(2):165-97. PubMed ID: 19441917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced degradation of protein kinases by bifunctional small molecules: a next-generation strategy.
    Groppe JC
    Expert Opin Drug Discov; 2019 Dec; 14(12):1237-1253. PubMed ID: 31513432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.